Table 1 Baseline characteristics
E group (n = 21) | D group (n = 12) | p-value | |
|---|---|---|---|
Age, years | 64.7 ± 14.6 | 61.1 ± 7.2 | 0.261 |
Male, n | 12 (57.1%) | 8 (66.7%) | 0.590 |
Chronic kidney disease | 5 (23.8) | 4 (33.3) | 0.555 |
Marfan syndrome | 1 (4) | 0 (0) | 0.443 |
DeBakey's classification, n (%) | |||
I | 17 (81.0) | 11 (91.7) | 0.865 |
II | 4 (19.0) | 1 (8.3) | 0.409 |
Complete thrombosed FL | 1 (4.7) | 2 (16.7) | 0.252 |
Preoperative comorbidity, n (%) | |||
Cardiac tamponade | 5 (23.8) | 0 (0) | 0.067 |
Moderate aortic regurgitation | 2 (9.5) | 2 (16) | 0.545 |
Coronary ischemia | 2 (9.5) | 1 (8.3) | 0.909 |
Cerebral ischemia | 2 (9.5) | 2 (16.7) | 0.545 |
Renal ischemia | 2 (9.5) | 3 (25.0) | 0.233 |
Visceral ischemia | 1 (4.7) | 2 (16.7) | 0.252 |
Limb ischemia | 2 (9.5) | 1 (8.3) | 0.909 |
Platelets on arrival, × 10^3/μL | 18.3 ± 8.3 | 17.4 ± 6.3 | 0.613 |
Preoperative platelets, × 10^3/μL | 18.3 ± 8.4 | 18.1 ± 9.5 | 0.765 |
Fibrinogen on arrival, mg/dL | 293.4 ± 165.3 | 174.3 ± 109.1 | 0.038 |
Preoperative fibrinogen, mg/dL | 293.4 ± 165.4 | 408.8 ± 299.2 | 0.379 |